BACKGROUND: The role of aging, disease, medications, and mood disturbances in sleep disturbances (SD) in patients with Parkinson's disease (PD) is poorly understood, and the impact of SD on the quality of life of their caregivers (CG) largely undocumented. OBJECTIVES: To evaluate the pattern and determinants of disturbed sleep in PD patients complaining of SD, and in their primary CG. METHODS: A prospective evaluation of 40 non-demented patients with PD complaining of SD and 23 of their primary CG (all were spouses) was conducted using Pittsburgh Sleep Quality Index, Zung's self-rating depression and anxiety scales, Parkinson's Impact Scale (PIMS) (only for PD), and an additional sleep questionnaire. RESULTS: Eighty-four percent of patients were 'poor sleepers' with global sleep scores (GLSc) > 5. Other abnormalities were: excessive daytime sleepiness-57.5%, excessive daytime fatigue-72.5%, depression-51.5%, anxiety-63.1%, and abnormal PIMS score-83.8%. There was no correlation between the degree of sleep dysfunction and the age, severity, duration of PD or its treatment. Several component sleep scores correlated with anxiety scores, PIMS score with depression, and, subjects with GLSc > or = 10 had higher mean anxiety index. Daytime dysfunction (97.5%) was mainly associated with reduced enthusiasm, rather than excessive sleepiness. Among CG, 40% had a GLSc > 5, 21% had depression, and 10.5% had anxiety. Their depression, anxiety and sleep scores correlated with those of their spouses. CONCLUSIONS: PD patients with significant SD may represent a subset of patients with early, progressive degeneration of sleep centres, rather than an enhanced aging process. They are more susceptible mood disturbances, which correlate with the severity of sleep dysfunction. Sleep and mood disturbances also adversely affect the quality of life of spousal caregivers.
BACKGROUND: The role of aging, disease, medications, and mood disturbances in sleep disturbances (SD) in patients with Parkinson's disease (PD) is poorly understood, and the impact of SD on the quality of life of their caregivers (CG) largely undocumented. OBJECTIVES: To evaluate the pattern and determinants of disturbed sleep in PDpatients complaining of SD, and in their primary CG. METHODS: A prospective evaluation of 40 non-demented patients with PD complaining of SD and 23 of their primary CG (all were spouses) was conducted using Pittsburgh Sleep Quality Index, Zung's self-rating depression and anxiety scales, Parkinson's Impact Scale (PIMS) (only for PD), and an additional sleep questionnaire. RESULTS: Eighty-four percent of patients were 'poor sleepers' with global sleep scores (GLSc) > 5. Other abnormalities were: excessive daytime sleepiness-57.5%, excessive daytime fatigue-72.5%, depression-51.5%, anxiety-63.1%, and abnormal PIMS score-83.8%. There was no correlation between the degree of sleep dysfunction and the age, severity, duration of PD or its treatment. Several component sleep scores correlated with anxiety scores, PIMS score with depression, and, subjects with GLSc > or = 10 had higher mean anxiety index. Daytime dysfunction (97.5%) was mainly associated with reduced enthusiasm, rather than excessive sleepiness. Among CG, 40% had a GLSc > 5, 21% had depression, and 10.5% had anxiety. Their depression, anxiety and sleep scores correlated with those of their spouses. CONCLUSIONS:PDpatients with significant SD may represent a subset of patients with early, progressive degeneration of sleep centres, rather than an enhanced aging process. They are more susceptible mood disturbances, which correlate with the severity of sleep dysfunction. Sleep and mood disturbances also adversely affect the quality of life of spousal caregivers.
Authors: Sara Carney; Theresa Koetters; Maria Cho; Claudia West; Steven M Paul; Laura Dunn; Bradley E Aouizerat; Marylin Dodd; Bruce Cooper; Kathryn Lee; William Wara; Patrick Swift; Christine Miaskowski Journal: J Clin Oncol Date: 2011-01-31 Impact factor: 44.544
Authors: Eva Havlikova; Jitse P van Dijk; Iveta Nagyova; Jaroslav Rosenberger; Berrie Middel; Tatiana Dubayova; Zuzana Gdovinova; Johan W Groothoff Journal: J Neurol Date: 2011-05-26 Impact factor: 4.849
Authors: Anand Dhruva; Kathryn Lee; Steven M Paul; Claudia West; Laura Dunn; Marylin Dodd; Bradley E Aouizerat; Bruce Cooper; Patrick Swift; Christine Miaskowski Journal: Cancer Nurs Date: 2012 Jan-Feb Impact factor: 2.592
Authors: Claire E Koljack; Janis Miyasaki; Lindsay P Prizer; Maya Katz; Nick Galifianakis; Stefan H Sillau; Benzi M Kluger Journal: J Palliat Med Date: 2021-11-24 Impact factor: 2.947
Authors: Marco D'Amelio; Valeria Terruso; Barbara Palmeri; Norma Di Benedetto; Giorgia Famoso; Paolo Cottone; Paolo Aridon; Paolo Ragonese; Giovanni Savettieri Journal: Neurol Sci Date: 2009-02-03 Impact factor: 3.307